Pfizer and Novo Nordisk have underperformed the market over the past year. Pharmaceutical giants Pfizer (NYSE: PFE) and Novo ...

While no vision loss was noted, researchers observed slight corneal thickening and decreased endothelial cell count, prompting calls for close monitoring in vulnerable individuals.